Search

Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols.

… Tuesday, October 9, 2018 Abbreviated breast magnetic resonance imaging is a cost-effective screening tool that should be made available to patients with an average lifetime risk of breast cancer, according to our recent review of protocols. Abbreviated breast MRI provides high diagnostic accuracy with

Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute.

… Monday, June 30, 2025 Danny Khalil, MD, PhD, medical oncologist and immunotherapy specialist at Memorial Sloan Kettering Cancer Center (MSK), has won a 2025 Scholar-Innovator Award from the Harrington Discovery Institute. Harrington Discovery Institute Scholar-Innovator Awards support the development

Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.

… Friday, January 11, 2019 Summary Immunotherapy drugs called checkpoint inhibitors can be very effective but don’t work for most people with prostate cancer . A small subset of men whose prostate tumors have a genetic abnormality called high microsatellite instability do respond to the drugs. Genetic

… Tuesday, August 21, 2012 Summary A team of researchers has made a breakthrough in solving a problem that has defied biologists for decades: How to compute a protein’s three-dimensional structure, or shape, based on genetic information. The discovery could accelerate diverse areas of biomedical discovery

This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.

… Tuesday, August 27, 2019 Summary The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found. Cells can die in several ways. One such method, discovered only within the past decade, is ferroptosis — literally

In a recently published paper MSK's Jun Mao explores the global challenges of cancer control and the current status of integrative oncology, offering recommendations to improve access to safe, effective, evidence-based, and culturally sensitive cancer care.

… Thursday, November 18, 2021 Cancer is a global health challenge that impacts countries large and small, affluent and impoverished. With population growth and aging, and success in the management of other acute and chronic diseases, the number of new cancer cases is expected to rise over the next two

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Thursday, April 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Katharine Hsu Named Director of Tri-Institutional MD-PhD Program Katharine Hsu MSK’s Katharine Hsu, MD, PhD , has been named director of the Tri-Institutional MD-PhD Program , a joint

A novel treatment for prostate cancer involves a light-sensitive drug that destroys small tumors and the blood vessels that feed them.

… Monday, September 18, 2017 Summary Treatment of prostate cancer involves the risk of complications that can reduce quality of life. MSK researchers are exploring a new technology called vascular-targeted photodynamic therapy to help alleviate this risk. It can destroy small prostate tumors with a drug

The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center and the Memorial Sloan Kettering Cancer Center Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection.

… Monday, October 5, 2009 The new Evelyn H. Lauder Breast Center of Memorial Sloan Kettering Cancer Center (MSKCC) and the MSKCC Imaging Center have opened, offering patients the most advanced outpatient services for cancer diagnosis and breast cancer treatment and detection. VIDEO | 5:00 Virtual Tour

Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.

… Wednesday, January 26, 2022 Craig B. Thompson, MD , President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State ’s 2022 Health Care Power 100 list . The prestigious Health Care Power list recognizes the most influential public health officials, hospital executives